Move to let patents lapse will allow cheaper generic versions to come on to the market without the threat of legal actionGlaxoSmithKline is taking action to obtain medicines more affordable in developing countries,including waiving patent protection for unique drugs in the world’s poorest nations.
Britain’s biggest drugmaker said it would not file patents for unique medicines in the poorest countries, such as Afghanistan, or Rwanda and Cambodia,allowing cheaper generic versions to come on the market without the threat of legal action. Continue reading...
Source: theguardian.com